Name: Bugging Cancer: Daring to Dream (en Inglés)
Price: 34420.00 CLP
Availability: InStock
Author: Chakrabarty, Ananda M.
ISBN: 9781934899366

portada Bugging Cancer: Daring to Dream (en Inglés)

Formato

Libro Físico

Autor

Ananda M. Chakrabarty

Editorial

Logos Press

Idioma

Inglés

N° páginas

222

Encuadernación

Tapa Blanda

Dimensiones

21.6 x 14.0 x 1.2 cm

Peso

0.26 kg.

ISBN13

9781934899366

Categorías

Ficción literaria

Bugging Cancer: Daring to Dream (en Inglés)

Ananda M. Chakrabarty (Autor) · Logos Press · Tapa Blanda

Libro Nuevo

$ 34.420

$ 47.800

Ahorras: $ 13.380

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 01 de Agosto y el Martes 13 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Bugging Cancer: Daring to Dream (en Inglés)"

The 1980 Supreme Court case of Diamond v. Chakrabarty was transformative for the biotechnology industry. It saw the Supreme Court allow Ananda Chakrabarty's patents on living organisms, and paved the way for commercial biotechnology. Decades later, Chakrabarty is still an active researcher, and he is now working to develop cancer therapeutics based on symbiotic bacteria. In Bugging Cancer, Chakrabarty and his colleagues at the Chicago Oncogroup have written a compelling dramatic thriller that portrays a fictional story based on this real-life work. Bugging Cancer is a fictional book, based on real scientific progress in using bacteria and bacterial proteins to attack malignant tumor cells. Scientific results are extended in a fictional way to describe the cancer-fighting power of an imaginary bacterial protein termed neelazin. The book also mirrors present-day issues, including international competition for scientific talent, issues in patent law, research ethics, and financing. Written by a team of seasoned scientific and business professionals, Bugging Cancer is sure to appeal to scientific researchers, patent attorneys, physicians, and any anyone else interested in healthcare and scientific innovation.